A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study

The burden of influenza in children is increasingly appreciated; some middle-income countries are considering support for influenza vaccine programs. To support decision-making, methods to estimate the potential impact of proposed programs are needed. Using Thailand as a case-study, we present a mod...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 29; no. 26; pp. 4416 - 4421
Main Authors: Dawood, Fatimah S., Fry, Alicia M., Muangchana, Charung, Sanasuttipun, Wiwan, Baggett, Henry C., Chunsuttiwat, Supamit, Maloney, Susan A., Simmerman, James Mark
Format: Journal Article
Language:English
Published: Kidlington Elsevier Ltd 10.06.2011
Elsevier
Elsevier Limited
Subjects:
ISSN:0264-410X, 1873-2518, 1873-2518
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The burden of influenza in children is increasingly appreciated; some middle-income countries are considering support for influenza vaccine programs. To support decision-making, methods to estimate the potential impact of proposed programs are needed. Using Thailand as a case-study, we present a model that uses surveillance data, published vaccine effectiveness estimates, and vaccination coverage assumptions to estimate the impact of influenza vaccination on pediatric influenza pneumonia hospitalizations. Approximately 56,000 influenza pneumonia hospitalizations occur annually among children aged <18 years in Thailand; 23,700 (41%) may be vaccine-preventable. Vaccination of 85% of Thai children aged 7 months–4 years might prevent 30% of all pediatric influenza pneumonia hospitalizations in Thailand.
Bibliography:http://dx.doi.org/10.1016/j.vaccine.2011.03.099
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2011.03.099